Loading…
Complications in pulmonary vein isolation in the Netherlands Heart Registration differ with sex and ablation technique
Abstract Aims Pulmonary vein isolation (PVI) has become a cornerstone of the invasive treatment of atrial fibrillation. Severe complications are reported in 1–3% of patients. This study aims to compare complications and follow-up outcome of PVI in patients with atrial fibrillation. Methods and resu...
Saved in:
Published in: | Europace (London, England) England), 2021-02, Vol.23 (2), p.216-225 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c377t-505fa311c405b3e0e78d06f3b1471957fb24f753b298e3353e2d133aef6bfcab3 |
---|---|
cites | cdi_FETCH-LOGICAL-c377t-505fa311c405b3e0e78d06f3b1471957fb24f753b298e3353e2d133aef6bfcab3 |
container_end_page | 225 |
container_issue | 2 |
container_start_page | 216 |
container_title | Europace (London, England) |
container_volume | 23 |
creator | Mol, Daniel Houterman, Saskia Balt, Jippe C Bhagwandien, Rohit E Blaauw, Yuri Delnoy, Peter-Paul H van Driel, Vincent J Driessen, Antoine H Folkeringa, Richard J Hassink, Rutger J van Huysduynen, Bart Hooft Luermans, Justin G Ouss, Alexandre J Stevenhagen, Yorick J van Veghel, Dennis Westra, Sjoerd W de Jong, Jonas S de Groot, Joris R |
description | Abstract
Aims
Pulmonary vein isolation (PVI) has become a cornerstone of the invasive treatment of atrial fibrillation. Severe complications are reported in 1–3% of patients. This study aims to compare complications and follow-up outcome of PVI in patients with atrial fibrillation.
Methods and results
The data were extracted from the Netherlands Heart Registration. Procedural and follow-up outcomes in patients treated with conventional radiofrequency (C-RF), multielectrode phased RF (Ph-RF), or cryoballoon (CB) ablation from 2012 to 2017 were compared. Subgroup analysis was performed to identify variables associated with complications and repeat ablations. In total, 13 823 patients (69% male) were included. The reported complication incidence was 3.6%. Patients treated with C-RF developed more cardiac tamponades (C-RF 0.8% vs. Ph-RF 0.3% vs. CB 0.3%, P ≤ 0.001) and vascular complications (C-RF 1.7% vs. Ph-RF 1.2% vs. CB 1.3%, P ≤ 0.001). Ph-RF was associated with fewer bleeding complications (C-RF: 1.0% vs. Ph-RF: 0.4% vs. CB: 0.7%, P = 0.020). Phrenic nerve palsy mainly occurred in patients treated with CB (C-RF: 0.1% vs. Ph-RF: 0.2% vs. CB: 1.5%, P ≤ 0.001). In total, 18.4% of patients were referred for repeat ablation within 1 year. Female sex, age, and CHA2DS2-VASc were independent risk factors for cardiac tamponade and bleeding complications, with an adjusted OR for female patients of 2.97 (95% CI 1.98–4.45) and 2.02 (95% CI 1.03–4.00) respectively.
Conclusion
The reported complication rate during PVI was low. Patients treated with C-RF ablation were more likely to develop cardiac tamponades and vascular complications. Female sex was associated with more cardiac tamponade and bleeding complications.
Graphical Abstract |
doi_str_mv | 10.1093/europace/euaa255 |
format | article |
fullrecord | <record><control><sourceid>proquest_TOX</sourceid><recordid>TN_cdi_proquest_miscellaneous_2457277324</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/europace/euaa255</oup_id><sourcerecordid>2457277324</sourcerecordid><originalsourceid>FETCH-LOGICAL-c377t-505fa311c405b3e0e78d06f3b1471957fb24f753b298e3353e2d133aef6bfcab3</originalsourceid><addsrcrecordid>eNqFkM9LwzAUx4Mobk7vniRHQar50SzrUYY6QRREzyVtX1ykbWqSTv3vzWzn1Uvywvu87wsfhE4puaQk41fQO9upEmKhFBNiD02p4CxhJGP7sSZZlgjKsgk68v6dECJZJg7RhHOaUirYFG2WtulqU6pgbOuxaXHX141tlfvGG4hP423929z2whrwI8TT1aqtPF6BcgE_w5vxwQ1UZbQGhz9NWGMPXzhyWBVjRIBy3ZqPHo7RgVa1h5PxnqHX25uX5Sp5eLq7X14_JCWXMiSCCK04pWVKRMGBgFxUZK55QVNJMyF1wVItBS9YtgDOBQdWUc4V6HmhS1XwGTofcjtn41of8sb4Eur4fbC9z1kqJJOSszSiZEBLZ713oPPOmSZ6yCnJt7bzne18tB1Hzsb0vmig-hvY6Y3AxQDYvvs_7gcR7o_G</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2457277324</pqid></control><display><type>article</type><title>Complications in pulmonary vein isolation in the Netherlands Heart Registration differ with sex and ablation technique</title><source>OUP_牛津大学出版社OA刊</source><creator>Mol, Daniel ; Houterman, Saskia ; Balt, Jippe C ; Bhagwandien, Rohit E ; Blaauw, Yuri ; Delnoy, Peter-Paul H ; van Driel, Vincent J ; Driessen, Antoine H ; Folkeringa, Richard J ; Hassink, Rutger J ; van Huysduynen, Bart Hooft ; Luermans, Justin G ; Ouss, Alexandre J ; Stevenhagen, Yorick J ; van Veghel, Dennis ; Westra, Sjoerd W ; de Jong, Jonas S ; de Groot, Joris R</creator><creatorcontrib>Mol, Daniel ; Houterman, Saskia ; Balt, Jippe C ; Bhagwandien, Rohit E ; Blaauw, Yuri ; Delnoy, Peter-Paul H ; van Driel, Vincent J ; Driessen, Antoine H ; Folkeringa, Richard J ; Hassink, Rutger J ; van Huysduynen, Bart Hooft ; Luermans, Justin G ; Ouss, Alexandre J ; Stevenhagen, Yorick J ; van Veghel, Dennis ; Westra, Sjoerd W ; de Jong, Jonas S ; de Groot, Joris R ; Netherlands Heart Registration Ablation Registration Committee ; the Netherlands Heart Registration Ablation Registration Committee</creatorcontrib><description>Abstract
Aims
Pulmonary vein isolation (PVI) has become a cornerstone of the invasive treatment of atrial fibrillation. Severe complications are reported in 1–3% of patients. This study aims to compare complications and follow-up outcome of PVI in patients with atrial fibrillation.
Methods and results
The data were extracted from the Netherlands Heart Registration. Procedural and follow-up outcomes in patients treated with conventional radiofrequency (C-RF), multielectrode phased RF (Ph-RF), or cryoballoon (CB) ablation from 2012 to 2017 were compared. Subgroup analysis was performed to identify variables associated with complications and repeat ablations. In total, 13 823 patients (69% male) were included. The reported complication incidence was 3.6%. Patients treated with C-RF developed more cardiac tamponades (C-RF 0.8% vs. Ph-RF 0.3% vs. CB 0.3%, P ≤ 0.001) and vascular complications (C-RF 1.7% vs. Ph-RF 1.2% vs. CB 1.3%, P ≤ 0.001). Ph-RF was associated with fewer bleeding complications (C-RF: 1.0% vs. Ph-RF: 0.4% vs. CB: 0.7%, P = 0.020). Phrenic nerve palsy mainly occurred in patients treated with CB (C-RF: 0.1% vs. Ph-RF: 0.2% vs. CB: 1.5%, P ≤ 0.001). In total, 18.4% of patients were referred for repeat ablation within 1 year. Female sex, age, and CHA2DS2-VASc were independent risk factors for cardiac tamponade and bleeding complications, with an adjusted OR for female patients of 2.97 (95% CI 1.98–4.45) and 2.02 (95% CI 1.03–4.00) respectively.
Conclusion
The reported complication rate during PVI was low. Patients treated with C-RF ablation were more likely to develop cardiac tamponades and vascular complications. Female sex was associated with more cardiac tamponade and bleeding complications.
Graphical Abstract</description><identifier>ISSN: 1099-5129</identifier><identifier>EISSN: 1532-2092</identifier><identifier>DOI: 10.1093/europace/euaa255</identifier><identifier>PMID: 33141152</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><ispartof>Europace (London, England), 2021-02, Vol.23 (2), p.216-225</ispartof><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com. 2020</rights><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c377t-505fa311c405b3e0e78d06f3b1471957fb24f753b298e3353e2d133aef6bfcab3</citedby><cites>FETCH-LOGICAL-c377t-505fa311c405b3e0e78d06f3b1471957fb24f753b298e3353e2d133aef6bfcab3</cites><orcidid>0000-0002-0746-4903</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1604,27924,27925</link.rule.ids><linktorsrc>$$Uhttps://dx.doi.org/10.1093/europace/euaa255$$EView_record_in_Oxford_University_Press$$FView_record_in_$$GOxford_University_Press</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33141152$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mol, Daniel</creatorcontrib><creatorcontrib>Houterman, Saskia</creatorcontrib><creatorcontrib>Balt, Jippe C</creatorcontrib><creatorcontrib>Bhagwandien, Rohit E</creatorcontrib><creatorcontrib>Blaauw, Yuri</creatorcontrib><creatorcontrib>Delnoy, Peter-Paul H</creatorcontrib><creatorcontrib>van Driel, Vincent J</creatorcontrib><creatorcontrib>Driessen, Antoine H</creatorcontrib><creatorcontrib>Folkeringa, Richard J</creatorcontrib><creatorcontrib>Hassink, Rutger J</creatorcontrib><creatorcontrib>van Huysduynen, Bart Hooft</creatorcontrib><creatorcontrib>Luermans, Justin G</creatorcontrib><creatorcontrib>Ouss, Alexandre J</creatorcontrib><creatorcontrib>Stevenhagen, Yorick J</creatorcontrib><creatorcontrib>van Veghel, Dennis</creatorcontrib><creatorcontrib>Westra, Sjoerd W</creatorcontrib><creatorcontrib>de Jong, Jonas S</creatorcontrib><creatorcontrib>de Groot, Joris R</creatorcontrib><creatorcontrib>Netherlands Heart Registration Ablation Registration Committee</creatorcontrib><creatorcontrib>the Netherlands Heart Registration Ablation Registration Committee</creatorcontrib><title>Complications in pulmonary vein isolation in the Netherlands Heart Registration differ with sex and ablation technique</title><title>Europace (London, England)</title><addtitle>Europace</addtitle><description>Abstract
Aims
Pulmonary vein isolation (PVI) has become a cornerstone of the invasive treatment of atrial fibrillation. Severe complications are reported in 1–3% of patients. This study aims to compare complications and follow-up outcome of PVI in patients with atrial fibrillation.
Methods and results
The data were extracted from the Netherlands Heart Registration. Procedural and follow-up outcomes in patients treated with conventional radiofrequency (C-RF), multielectrode phased RF (Ph-RF), or cryoballoon (CB) ablation from 2012 to 2017 were compared. Subgroup analysis was performed to identify variables associated with complications and repeat ablations. In total, 13 823 patients (69% male) were included. The reported complication incidence was 3.6%. Patients treated with C-RF developed more cardiac tamponades (C-RF 0.8% vs. Ph-RF 0.3% vs. CB 0.3%, P ≤ 0.001) and vascular complications (C-RF 1.7% vs. Ph-RF 1.2% vs. CB 1.3%, P ≤ 0.001). Ph-RF was associated with fewer bleeding complications (C-RF: 1.0% vs. Ph-RF: 0.4% vs. CB: 0.7%, P = 0.020). Phrenic nerve palsy mainly occurred in patients treated with CB (C-RF: 0.1% vs. Ph-RF: 0.2% vs. CB: 1.5%, P ≤ 0.001). In total, 18.4% of patients were referred for repeat ablation within 1 year. Female sex, age, and CHA2DS2-VASc were independent risk factors for cardiac tamponade and bleeding complications, with an adjusted OR for female patients of 2.97 (95% CI 1.98–4.45) and 2.02 (95% CI 1.03–4.00) respectively.
Conclusion
The reported complication rate during PVI was low. Patients treated with C-RF ablation were more likely to develop cardiac tamponades and vascular complications. Female sex was associated with more cardiac tamponade and bleeding complications.
Graphical Abstract</description><issn>1099-5129</issn><issn>1532-2092</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqFkM9LwzAUx4Mobk7vniRHQar50SzrUYY6QRREzyVtX1ykbWqSTv3vzWzn1Uvywvu87wsfhE4puaQk41fQO9upEmKhFBNiD02p4CxhJGP7sSZZlgjKsgk68v6dECJZJg7RhHOaUirYFG2WtulqU6pgbOuxaXHX141tlfvGG4hP423929z2whrwI8TT1aqtPF6BcgE_w5vxwQ1UZbQGhz9NWGMPXzhyWBVjRIBy3ZqPHo7RgVa1h5PxnqHX25uX5Sp5eLq7X14_JCWXMiSCCK04pWVKRMGBgFxUZK55QVNJMyF1wVItBS9YtgDOBQdWUc4V6HmhS1XwGTofcjtn41of8sb4Eur4fbC9z1kqJJOSszSiZEBLZ713oPPOmSZ6yCnJt7bzne18tB1Hzsb0vmig-hvY6Y3AxQDYvvs_7gcR7o_G</recordid><startdate>20210205</startdate><enddate>20210205</enddate><creator>Mol, Daniel</creator><creator>Houterman, Saskia</creator><creator>Balt, Jippe C</creator><creator>Bhagwandien, Rohit E</creator><creator>Blaauw, Yuri</creator><creator>Delnoy, Peter-Paul H</creator><creator>van Driel, Vincent J</creator><creator>Driessen, Antoine H</creator><creator>Folkeringa, Richard J</creator><creator>Hassink, Rutger J</creator><creator>van Huysduynen, Bart Hooft</creator><creator>Luermans, Justin G</creator><creator>Ouss, Alexandre J</creator><creator>Stevenhagen, Yorick J</creator><creator>van Veghel, Dennis</creator><creator>Westra, Sjoerd W</creator><creator>de Jong, Jonas S</creator><creator>de Groot, Joris R</creator><general>Oxford University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0746-4903</orcidid></search><sort><creationdate>20210205</creationdate><title>Complications in pulmonary vein isolation in the Netherlands Heart Registration differ with sex and ablation technique</title><author>Mol, Daniel ; Houterman, Saskia ; Balt, Jippe C ; Bhagwandien, Rohit E ; Blaauw, Yuri ; Delnoy, Peter-Paul H ; van Driel, Vincent J ; Driessen, Antoine H ; Folkeringa, Richard J ; Hassink, Rutger J ; van Huysduynen, Bart Hooft ; Luermans, Justin G ; Ouss, Alexandre J ; Stevenhagen, Yorick J ; van Veghel, Dennis ; Westra, Sjoerd W ; de Jong, Jonas S ; de Groot, Joris R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c377t-505fa311c405b3e0e78d06f3b1471957fb24f753b298e3353e2d133aef6bfcab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mol, Daniel</creatorcontrib><creatorcontrib>Houterman, Saskia</creatorcontrib><creatorcontrib>Balt, Jippe C</creatorcontrib><creatorcontrib>Bhagwandien, Rohit E</creatorcontrib><creatorcontrib>Blaauw, Yuri</creatorcontrib><creatorcontrib>Delnoy, Peter-Paul H</creatorcontrib><creatorcontrib>van Driel, Vincent J</creatorcontrib><creatorcontrib>Driessen, Antoine H</creatorcontrib><creatorcontrib>Folkeringa, Richard J</creatorcontrib><creatorcontrib>Hassink, Rutger J</creatorcontrib><creatorcontrib>van Huysduynen, Bart Hooft</creatorcontrib><creatorcontrib>Luermans, Justin G</creatorcontrib><creatorcontrib>Ouss, Alexandre J</creatorcontrib><creatorcontrib>Stevenhagen, Yorick J</creatorcontrib><creatorcontrib>van Veghel, Dennis</creatorcontrib><creatorcontrib>Westra, Sjoerd W</creatorcontrib><creatorcontrib>de Jong, Jonas S</creatorcontrib><creatorcontrib>de Groot, Joris R</creatorcontrib><creatorcontrib>Netherlands Heart Registration Ablation Registration Committee</creatorcontrib><creatorcontrib>the Netherlands Heart Registration Ablation Registration Committee</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Europace (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Mol, Daniel</au><au>Houterman, Saskia</au><au>Balt, Jippe C</au><au>Bhagwandien, Rohit E</au><au>Blaauw, Yuri</au><au>Delnoy, Peter-Paul H</au><au>van Driel, Vincent J</au><au>Driessen, Antoine H</au><au>Folkeringa, Richard J</au><au>Hassink, Rutger J</au><au>van Huysduynen, Bart Hooft</au><au>Luermans, Justin G</au><au>Ouss, Alexandre J</au><au>Stevenhagen, Yorick J</au><au>van Veghel, Dennis</au><au>Westra, Sjoerd W</au><au>de Jong, Jonas S</au><au>de Groot, Joris R</au><aucorp>Netherlands Heart Registration Ablation Registration Committee</aucorp><aucorp>the Netherlands Heart Registration Ablation Registration Committee</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Complications in pulmonary vein isolation in the Netherlands Heart Registration differ with sex and ablation technique</atitle><jtitle>Europace (London, England)</jtitle><addtitle>Europace</addtitle><date>2021-02-05</date><risdate>2021</risdate><volume>23</volume><issue>2</issue><spage>216</spage><epage>225</epage><pages>216-225</pages><issn>1099-5129</issn><eissn>1532-2092</eissn><abstract>Abstract
Aims
Pulmonary vein isolation (PVI) has become a cornerstone of the invasive treatment of atrial fibrillation. Severe complications are reported in 1–3% of patients. This study aims to compare complications and follow-up outcome of PVI in patients with atrial fibrillation.
Methods and results
The data were extracted from the Netherlands Heart Registration. Procedural and follow-up outcomes in patients treated with conventional radiofrequency (C-RF), multielectrode phased RF (Ph-RF), or cryoballoon (CB) ablation from 2012 to 2017 were compared. Subgroup analysis was performed to identify variables associated with complications and repeat ablations. In total, 13 823 patients (69% male) were included. The reported complication incidence was 3.6%. Patients treated with C-RF developed more cardiac tamponades (C-RF 0.8% vs. Ph-RF 0.3% vs. CB 0.3%, P ≤ 0.001) and vascular complications (C-RF 1.7% vs. Ph-RF 1.2% vs. CB 1.3%, P ≤ 0.001). Ph-RF was associated with fewer bleeding complications (C-RF: 1.0% vs. Ph-RF: 0.4% vs. CB: 0.7%, P = 0.020). Phrenic nerve palsy mainly occurred in patients treated with CB (C-RF: 0.1% vs. Ph-RF: 0.2% vs. CB: 1.5%, P ≤ 0.001). In total, 18.4% of patients were referred for repeat ablation within 1 year. Female sex, age, and CHA2DS2-VASc were independent risk factors for cardiac tamponade and bleeding complications, with an adjusted OR for female patients of 2.97 (95% CI 1.98–4.45) and 2.02 (95% CI 1.03–4.00) respectively.
Conclusion
The reported complication rate during PVI was low. Patients treated with C-RF ablation were more likely to develop cardiac tamponades and vascular complications. Female sex was associated with more cardiac tamponade and bleeding complications.
Graphical Abstract</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>33141152</pmid><doi>10.1093/europace/euaa255</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-0746-4903</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | ISSN: 1099-5129 |
ispartof | Europace (London, England), 2021-02, Vol.23 (2), p.216-225 |
issn | 1099-5129 1532-2092 |
language | eng |
recordid | cdi_proquest_miscellaneous_2457277324 |
source | OUP_牛津大学出版社OA刊 |
title | Complications in pulmonary vein isolation in the Netherlands Heart Registration differ with sex and ablation technique |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T05%3A19%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_TOX&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Complications%20in%20pulmonary%20vein%20isolation%20in%20the%20Netherlands%20Heart%20Registration%20differ%20with%20sex%20and%20ablation%20technique&rft.jtitle=Europace%20(London,%20England)&rft.au=Mol,%20Daniel&rft.aucorp=Netherlands%20Heart%20Registration%20Ablation%20Registration%20Committee&rft.date=2021-02-05&rft.volume=23&rft.issue=2&rft.spage=216&rft.epage=225&rft.pages=216-225&rft.issn=1099-5129&rft.eissn=1532-2092&rft_id=info:doi/10.1093/europace/euaa255&rft_dat=%3Cproquest_TOX%3E2457277324%3C/proquest_TOX%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c377t-505fa311c405b3e0e78d06f3b1471957fb24f753b298e3353e2d133aef6bfcab3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2457277324&rft_id=info:pmid/33141152&rft_oup_id=10.1093/europace/euaa255&rfr_iscdi=true |